KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Non-Current Assets (2016 - 2025)

Evolent Health has reported Non-Current Assets over the past 12 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly results put Non-Current Assets at $1.4 billion for Q4 2025, down 28.1% from a year ago — trailing twelve months through Dec 2025 was $7.1 billion (down 9.24% YoY), and the annual figure for FY2025 was $1.4 billion, down 28.1%.
  • Non-Current Assets for Q4 2025 was $1.4 billion at Evolent Health, down from $1.9 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for EVH hit a ceiling of $2.1 billion in Q1 2023 and a floor of $775.3 million in Q3 2021.
  • Median Non-Current Assets over the past 5 years was $1.9 billion (2025), compared with a mean of $1.5 billion.
  • Peak annual rise in Non-Current Assets hit 23105.44% in 2021, while the deepest fall reached 33.13% in 2021.
  • Evolent Health's Non-Current Assets stood at $895.5 million in 2021, then soared by 49.55% to $1.3 billion in 2022, then surged by 49.09% to $2.0 billion in 2023, then dropped by 2.97% to $1.9 billion in 2024, then fell by 28.1% to $1.4 billion in 2025.
  • The last three reported values for Non-Current Assets were $1.4 billion (Q4 2025), $1.9 billion (Q3 2025), and $1.9 billion (Q2 2025) per Business Quant data.